You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

GSK Pharma hits 52-week high; rises 11% in three days

Capital Market 

Glaxosmithkline Pharmaceuticals jumped 10.17% to Rs 1,780.3, rising for third trading session.

Shares of Glaxosmithkline Pharmaceuticals have surged 11.4% in three trading sessions from its previous closing low of Rs 1596.90 posted on 22 November 2021. The counter hit a 52-week high of Rs 1,824.65 in intraday today. The stock has increased 29% from its 52-week low of Rs 1379 recorded on 25 March 2021.

On the technical front, the stock's RSI (relative strength index) stood at 69.997. The RSI oscillates between zero and 100. Traditionally the RSI is considered overbought when above 70 and oversold when below 30.

The stock is trading above its 50 and 100 days simple moving average placed at 1541.48 and 1556.48 respectively. These levels will act as crucial support zones in near term.

GSK Pharma is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies. The company reported a 76% rise in standalone net profit to Rs 202.65 crore on a 12.8% increase in net sales to Rs 991.53 crore in Q2 FY22 over Q2 FY21.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, November 25 2021. 13:48 IST